knowledge -WSS

knowledge

author：explore 2025-10-02 22:57:18 - browse：2

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Do masks work? RCTs can't tell us

knowledge

WSS

To avoid data mishandling cases, universities eye AI and other tools

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Medical mystery: When a cough is not just a cough

Ask STAT: What do you want to know about ChatGPT in medicine?

Do masks work? RCTs can't tell us

Senators start work on Medicare physician payment reform

entertainment

knowledge

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

KalVista pill reduced swelling 'attacks' caused by genetic disease

Cancer drug shortages should be causing more outrage

Doctors' information doesn't help them choose wisely when sick

Walensky prepares to leave CDC — and Congress — behind

Private equity deals in Medicare Advantage declines

Supreme Court strikes down use of affirmative action

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The dental labor crisis is a moment of opportunity

explore

New guidelines on severe brain injury complicate already difficult decisions

Industry veterans launch new biotech VC with $310M

'Revelatory' study finds a smoking impact that remains after quitting

STAT's guide to the next generation of CAR

BioAge raises $170M for combination therapy with Zepbound

Vaccine advisory panel ACIP left half staffed by HHS

leisure time

Wikipedia

knowledge

Wikipedia